Previous studies have concurrently examined perfusion and diffusion characteristics of gliomas,48 including median nrCBV/ADC ratios.42 The present findings suggest that combined perfusion and diffusion metrics may be valuable in evaluating IDH inhibition given the individual associations of high nrCBV and low ADC with reduced PFS. The gene discussed is IDH1; the disease is central nervous system cancer.